INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

AZNASTRAZENECA PLC

CIK 0000901832

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score9
Connections6with evidence

AZN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SM
Sharma ManiSee remarks
AZNASTRAZENECA PLC
Grant or award
A$320
2 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    W STRATEGIES, LLCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
9
SM
Sharma ManiSVP, Group Controller
AZNASTRAZENECA PLC
Grant or award
A
$327
2 sh
Aug 6, 2026
Aug 7, 2026
traded Aug 6, 2026
+1d
SEC FORM 4

Evidence

  • ← Lobbied forevidence
    TARPLIN, DOWNS & YOUNG, LLCLDA Q1 2026 first quarter · Budget/appropriations, Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Sharma ManiSVP, Group Controller · Aug 7, 2026

    • Lobbying

    $3.96M reported · de-duplicated
    2026 Q2 $1.68M in-house2026 Q1 $2.28M in-house
    • TODD STRATEGY GROUP$80K2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations, Medicare/Medicaid, Health issues
    • W STRATEGIES, LLC$80K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • TODD STRATEGY GROUP$80K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • TIBER CREEK GROUP$80K2026 Q2 · posted Aug 26, 2026 · Health issues, FOR, Defense, Medicare/Medicaid
    • In-house report$2.28M2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Pharmacy, Taxation, Copyright/patent, TAR, Trade
    • W STRATEGIES, LLC$80K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • TIBER CREEK GROUP$80K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • In-house report$1.68M2026 Q2 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Pharmacy, Copyright/patent, TAR, Trade, Labor, Taxation
    • TARPLIN, DOWNS & YOUNG, LLC$80K2026 Q1 · posted Aug 26, 2026 · Budget/appropriations, Medicare/Medicaid, Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.